A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations
Open Access
- 22 September 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 40 (5), 1151-1159
- https://doi.org/10.1002/hep.20427
Abstract
Activation of hepatic stellate cells (HSCs) and other resident mesenchymal cells into myofibroblasts expressing alpha smooth muscle actin (αSMA) and collagen I is a key event in liver fibrogenesis. However, the temporal expression profiles of αSMA and collagen I genes in these cells is unknown. To address this question, we studied αSMA and collagen α1(I) transcriptional patterns in primary cultures of HSCs, and additionally, in an in vivo model of secondary biliary fibrosis using transgenic mice that express the Discomsoma sp. red fluorescent protein (RFP) and the enhanced green fluorescent protein (EGFP) reporter genes under direction of the mouse αSMA and collagen α1(I) promoter/enhancers, respectively. The αSMA-RFP mice were crossed with collagen-EGFP mice to generate double transgenic mice. Reporter gene expression in cultured HSCs demonstrated that both transgenes were induced at day 3 with continued expression through day 14. Interestingly, αSMA and collagen α1(I) transgenes were not coexpressed in all cells. Flow cytometry analysis showed three different patterns of gene expression: αSMA-RFP positive cells, collagen-EGFP positive cells, and cells expressing both transgenes. αSMA-only and αSMA/collagen expressing cells showed higher expression levels of synaptophysin, reelin, MMP13, TIMP1, and ICAM-1 compared to collagen-only expressing cells, as assessed by real-time PCR. Following bile duct ligation, αSMA and collagen α1(I) transgenes were differentially expressed by peribiliary, parenchymal and vascular fibrogenic cells. Peribiliary cells preferentially expressed collagen α1(I), while parenchymal myofibroblasts expressed both αSMA and collagen α1(I). In conclusion, these data demonstrate heterogeneity of gene expression in myofibroblastic cells during active fibrogenesis. These reporter mice provide a useful tool to further characterize fibrogenic cell types and to evaluate antifibrotic drugs. (Hepatology 2004.)Keywords
This publication has 34 references indexed in Scilit:
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Peribiliary myofibroblasts in biliary type liver fibrosisFrontiers in Bioscience-Landmark, 2002
- Activation of hepatic stellate cells - a key issue in liver fibrosisFrontiers in Bioscience-Landmark, 2002
- Hepatic Stellate Cells as a Target for the Treatment of Liver FibrosisSeminars in Liver Disease, 2001
- Hepatic stellate cell activation in nonalcoholic steatohepatitis and fatty liverHuman Pathology, 2000
- Synaptophysin: A Novel Marker for Human and Rat Hepatic Stellate CellsThe American Journal of Pathology, 1999
- Regulation of Smooth Muscle α-Actin Expression In Vivo Is Dependent on CArG Elements Within the 5′ and First Intron Promoter RegionsCirculation Research, 1999
- Quantitative Analysis of Liver Fibrosis and Stellate Cell Changes in Patients With Chronic Hepatitis C After Interferon TherapyAmerican Journal of Gastroenterology, 1999
- Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosisGastroenterology, 1990
- Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer.Journal of Clinical Investigation, 1988